FAP, June 5 (FAP)-according to the announcement of Anke Biology, the company recently obtained the "Notification of Type I Medical device record number" issued by Hefei Market Supervision Bureau. The acquisition of the above record certificate indicates that the company's new product sperm viability dye solution (eosin-aniline black method) and sperm chromomycin A3 dye solution have been approved to be put on the market.